Experimental stages—effect on MDSC, in the context of TB, yet to be evaluated. Troublesome risk of anti-TNF-α treatment resulting in reactivation of active disease, especially in latent infection cases. Human infection model. Here, TNF is linked to disease arising from reactivation of latent virus.